Revolution Medicines, Inc. (RVMD)

205.04 +5.18 (+2.59%) USD  |  NASDAQ  |  Sep 25, 16:00
205.87 +0.83 (+0.40%) After-Hours: 19:59
More

Revolution Medicines Research and Development Expense (Annual) : 978.68M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for RVMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 978.68M
December 31, 2024 584.60M
December 31, 2023 417.03M
December 31, 2022 248.03M
December 31, 2021 182.80M
Date Value
December 31, 2020 128.57M
December 31, 2019 91.16M
December 31, 2018 51.08M
December 31, 2017 26.59M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Moderna, Inc. 2.917B
Erasca, Inc. 92.85M
Tango Therapeutics, Inc. 129.88M
Arrowhead Pharmaceuticals, Inc. 585.26M
Intellia Therapeutics, Inc. 379.09M